title: Advances in migraine management.
abstract: New drugs and better understanding of the pathogenesis of migraine are improving the outlook for patients with this debilitating disorder. This paper reviews recent advances and outlines our approach.
authors.affiliation: Department of Internal Medicine, Cleveland Clinic Foundation, OH 44195, USA.
authors.forename: T A
authors.initials: TA
authors.lastname: Lewis
authors.forename: G D
authors.initials: GD
authors.lastname: Solomon
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use; D001676:Biofeedback, Psychology; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D003131:Combined Modality Therapy; D005544:Forecasting; D006801:Humans; D008487:Medical History Taking; D008881:Migraine Disorders / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D014635:Valproic Acid / Q000627:therapeutic use
chemical_list: D000319:Adrenergic beta-Antagonists; D000894:Anti-Inflammatory Agents, Non-Steroidal; D000928:Antidepressive Agents; D002121:Calcium Channel Blockers; D014635:Valproic Acid